COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 587: Articles 5861-5870  | Next

Impact of COVID-19 pandemic on the incidence of suicidal behaviors: a retrospective analysis of integrated electronic health records in a 7.5-million population
Valero-Bover, D., Fradera, M., Carot-Sans, G., Parra, I., Piera-Jimenez, J., Pontes, C., Palao-Vidal, D.
10.1101/2022.09.26.22280233 — Posted: 2022-09-26
Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015-2021A time-series analysis
Adamson, J., Chalmers, R., Thomas, D. R., Elwin, K., Robinson, G., Barrasa, A.
10.1101/2022.09.26.22280357 — Posted: 2022-09-26
Inhibition of Phosphodiesterase 12 results in Antiviral Activity against several RNA Viruses including SARS-CoV-2.
Karayiannis, P., Thursz, M., Sadiq, F., Tree, J., Beasley, D., Dejnirattisai, W., Mongkolsapaya, J., Screaton, G., Wand, M., Elmore, M., Miles, C., Matthews, I., Thomas, H.
10.1101/2022.09.23.509178 — Posted: 2022-09-26
Post-Concussion Assessment as a diagnostic and mechanistic framework for treating patients with Long COVID
Davidson, B., Noteboom, L., Pierro, H., Kantor, C., Stoot, D., Stoot, F., Linseman, D., Hale, T., Gorgens, K.
10.1101/2022.09.24.22280310 — Posted: 2022-09-25
The impact of COVID-19 vaccination in the US: averted burden of SARS-COV-2-related cases, hospitalizations and deaths
Yamana, T. K., Galanti, M., Pei, S., Di Fusco, M., Angulo, F. J., Moran, M., Khan, F., Swerdlow, D., Shaman, J.
10.1101/2022.09.23.22280281 — Posted: 2022-09-25
Healthcare system overstretch and in-hospital mortality of intubated COVID-19 patients in Greece: an updated analysis, September 2020 to April 2022
Lytras, T.
10.1101/2022.09.25.22280326 — Posted: 2022-09-25
A machine learning approach identifies unresolving secondary pneumonia as a contributor to mortality in patients with severe pneumonia, including COVID-19
Gao, C. A., Markov, N. S., Stoeger, T., Pawlowski, A. E., Kang, M., Nannapaneni, P., Grant, R. A., Pickens, C. O., Walter, J. M., Kruser, J. M., Rasmussen, L. V., Schneider, D., Starren, J., Donnelly, H. K., Donayre, A., Luo, Y., Budinger, G. S., Wunderink, R. G., Misharin, A. V., Singer, B. D., NU SCRIPT Study Investigators
10.1101/2022.09.23.22280118 — Posted: 2022-09-25
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.
Olawoye, I. B., Oluniyi, P. E., Parker, E., Oguzie, J. U., Uwanibe, J. N., Kayode, T. A., Ajogbasile, F. V., Olumade, T. J., Eromon, P., Abechi, P., Sobajo, T., Ugwu, C., Uwem, G., Ayoade, F., Akano, K., Akinlo, O. O., Akin-John, J. O., Oyejide, N., Ayo-Ale, O., Adegboyega, B., Chukwu, G. C., Adeleke, A., Ezekiel, G. O., Brimmo, F., Fayemi, O. O., Fred-Akintunwa, I., Yusuf, I. F., Ipaye, T. O., John, O., Muhammad, A. I., Nwodo, D. C., Ogunsanya, O. A., Okolie, J., Omoniyi, A. E., Omwanghe, I. B., Ope-ewe, O. O., Otitoola, S., Adedotun-Suleiman, K., Philip, C., Saibu, M. F., Sijuwola, A. E., Terkuma, C. A., Abu, A., Adeniji, J. A., Adewunmi, M. O., Adeyemi, O. O., Ahmed, R., Ahumibe, A., Ajayi, A. N., Akanbi, O., Akande, O., Akinola, M., Akinpelu, A., Akpede, G., Anieno, E., Atage, A. E., Ayansola, O., Baba, M., Babatunde, O., Oderinde, B. S., Benevolence, E., Blessing, O., Bob-Manuel, M., Bock-Oruma, A., Chris, A., Chukwu, C., Daramola, F., Donatus, A., Duruihuoma, R., Edna, Y., Ekeh, M., Ndoma, E., Ewah, R., Fajola, A., Fakayode, E. O., Fowotade, A., Gadzama, G., Igwe, D., Ikponmwosa, O., Isamotu, R. O., Jacqueline, A., John, A., Ekpo, J. J., Kida, I., Mba, N., Micheal, A., Tatfeng, M. Y., Moore-Igwe, W. B., Moses, A., Naregose, O., Ntia, N.-A., Nwafor, I., Odeh, E., Ogbaini, E., Ojide, K. C., Okogbenin, S., Okokhere, P., Okoro, S., Okwuraiwe, A., Olasunkanmi, O., Olayinka, O., Omoare, A., Omoruyi, E. C., Omunakwe, H. E., Ogah, E. O., Onwuamah, C., Onyia, V., Patience, A., Paulson, E., Racheal, O., Rita, E., Rosemary, G., Shaibu, J., Shaibu, J., Solomon, E., Ugwu, N., Ugwu, C. N., Ukwuaja, K., Wudiri, Z., Ndodo, N., Petros, B., Mcannis, B., Oshomah, C., Oladiji, F., Siddle, K. J., Audu, R., Salako, B. L., Schaffner, S., Park, D., Adetifa, I., Ihekweazu, C., Tomori, O., Happi, A. N., Folarin, O., Andersen, K. G., Sabeti, P. C., Happi, C. T.
10.1101/2022.09.24.22280269 — Posted: 2022-09-25
Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management
El-Zein, M., Ali, R., Farah, E., Botting-Provost, S., Franco, E. L., Survey Study Group
10.1101/2022.09.23.22279458 — Posted: 2022-09-25
Impact of COVID-19 on lifestyle and mental wellbeing in a drought-affected rural Australian population: A mixed method approach
Carlson, J., Chan, K., Gray, J., Xue, H., Reed, K., Bailey, J. K., Dutton, T., Osuagwu, U. L., Vines, R.
10.1101/2022.09.23.22280278 — Posted: 2022-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).